Triphase Accelerator Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Triphase Accelerator Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11323
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Triphase Accelerator Corp (Triphase Accelerator) is a biotechnology development company that acquires and develops novel therapeutics for the treatment of cancer. The company’s pipeline products comprise marizomib, a brain-penetrant proteasome inhibitor, which is developed in both intravenous and oral formulations for the treatment of hematologic malignancies and solid tumors; and TRPH-222, a novel site-specific antibody-drug conjugate in development for lymphona. Triphase Accelerator is active in licensing oncology products of various educational institutions, biotechnology and pharmaceutical companies. It also forms partnerships to produce proof of concept data for investors, partners, regulators, payers, and prescribers and patients. The company has operations in Canada and the US. Triphase Accelerator is headquartered in Toronto, Ontario, Canada.

Triphase Accelerator Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Triphase Accelerator Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Triphase Accelerator Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Triphase Accelerator Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Triphase Accelerator Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Triphase Accelerator Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Triphase Accelerator Corp, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Triphase Accelerator Enters into Agreement with Sunnybrook Research Institute 10
Triphase Accelerator Enters Into Co-Development Agreement With Celgene 11
Triphase Expands Co-Development Agreement with Celgene 12
Licensing Agreements 14
Catalent Enters into Licensing Agreement with Triphase Accelerator 14
PharmAbcine Enters into Licensing Agreement with Triphase Accelerator 15
Asset Transactions 16
Celgene Enters into Option Agreement to Acquire Assets of TRPH-222 from Triphase Accelerator 16
Celgene Acquires Marizomib from Triphase Accelerator 17
Celgene Enters into Option to Acquire VEGFR-2/TIE 2 Bi-Specific Antibody from Triphase 18
Acquisition 19
Triphase Research & Development Acquires Nereus Pharma 19
Triphase Accelerator Corp – Key Competitors 20
Triphase Accelerator Corp – Key Employees 21
Triphase Accelerator Corp – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Triphase Accelerator Corp, Pharmaceuticals & Healthcare, Key Facts 2
Triphase Accelerator Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Triphase Accelerator Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Triphase Accelerator Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Triphase Accelerator Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Triphase Accelerator Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Triphase Accelerator Enters into Agreement with Sunnybrook Research Institute 10
Triphase Accelerator Enters Into Co-Development Agreement With Celgene 11
Triphase Expands Co-Development Agreement with Celgene 12
Catalent Enters into Licensing Agreement with Triphase Accelerator 14
PharmAbcine Enters into Licensing Agreement with Triphase Accelerator 15
Celgene Enters into Option Agreement to Acquire Assets of TRPH-222 from Triphase Accelerator 16
Celgene Acquires Marizomib from Triphase Accelerator 17
Celgene Enters into Option to Acquire VEGFR-2/TIE 2 Bi-Specific Antibody from Triphase 18
Triphase Research & Development Acquires Nereus Pharma 19
Triphase Accelerator Corp, Key Competitors 20
Triphase Accelerator Corp, Key Employees 21
Triphase Accelerator Corp, Other Locations 22
Triphase Accelerator Corp, Subsidiaries 22

List of Figures
Triphase Accelerator Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Triphase Accelerator Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Triphase Accelerator Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Triphase Accelerator Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Triphase Accelerator Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Triphase Accelerator Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Triphase Accelerator Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Triphase Accelerator Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Triphase Accelerator Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Duke Energy Carolinas LLC:企業の発電所・SWOT分析2018
    Duke Energy Carolinas LLC - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Zurich Insurance Group Ltd:企業のM&A・事業提携・投資動向
    Zurich Insurance Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Zurich Insurance Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • PharmAthene Inc (PIP)-製薬・医療分野:企業M&A・提携分析
    Summary PharmAthene Inc (PharmAthene) is a pharmaceutical company that develops and commercializes medical counter measures to biological and chemical weapons. The company’s products include recombinant protective antigen anthrax vaccine, human monoclonal antibody antitoxin and recombinant BChE bios …
  • SMBC Trust Bank Private Banking:企業の戦略・SWOT・財務分析
    SMBC Trust Bank Private Banking - Strategy, SWOT and Corporate Finance Report Summary SMBC Trust Bank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Terma AS:企業の戦略・SWOT・財務情報
    Terma AS - Strategy, SWOT and Corporate Finance Report Summary Terma AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Fresh Del Monte Produce Inc (FDP):企業の財務・戦略的SWOT分析
    Fresh Del Monte Produce Inc (FDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Gulf Island Fabrication Inc (GIFI):企業の財務・戦略的SWOT分析
    Gulf Island Fabrication Inc (GIFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Tsogo Sun Holdings Ltd:企業のM&A・事業提携・投資動向
    Tsogo Sun Holdings Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tsogo Sun Holdings Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Medigen Biotechnology Corp (3176)-医療機器分野:企業M&A・提携分析
    Summary Medigen Biotechnology Corp (MBC) is a pharmaceutical company that carries out the research and development of biopharmaceuticals for the treatment of liver diseases and cancers. It focuses at developing new therapeutics, principally in the area of cancer and liver diseases. The company’s pro …
  • Radiation Monitoring Devices Inc:製品パイプライン分析
    Summary Radiation Monitoring Devices Inc (RMD), a subsidiary of Dynasil Corporation of America is a research and development company that provides solutions for security, medical and industrial applications. The company’s products include scintillators, APDs, cesium iodide, solid state photomultipli …
  • Zweites Deutsches Fernsehen:企業の戦略的SWOT分析
    Zweites Deutsches Fernsehen - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Sherritt International Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Sherritt International Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Sherritt International Corp Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehe …
  • United States Lime & Minerals Inc:企業の戦略・SWOT・財務分析
    United States Lime & Minerals Inc - Strategy, SWOT and Corporate Finance Report Summary United States Lime & Minerals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Turboatom (TATM):企業の財務・戦略的SWOT分析
    Turboatom (TATM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Trinity Biotech Plc (TRIB):製品パイプライン分析
    Summary Trinity Biotech Plc (Trinity Biotech) is a medical equipment company which develops, acquires, manufactures and distributes diagnostic systems for clinical laboratory and point-of-care sectors. The company’s product portfolio encompasses diagnostic tests and instruments that are used to dete …
  • Tosoh Corporation:企業の戦略・SWOT・財務情報
    Tosoh Corporation - Strategy, SWOT and Corporate Finance Report Summary Tosoh Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • BenevolentAI Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary BenevolentAI Ltd (BenevolentAI) is an artificial intelligence company that focuses on developing and applying artificial intelligence (AI) to produce new medicines for the treatment of diseases with unmet medical needs. The company’s platform enables scientists to design and develop new trea …
  • Parker Drilling Co (PKD):企業の財務・戦略的SWOT分析
    Parker Drilling Co (PKD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Arabian Bemco Contracting Co. Ltd.
    Arabian Bemco Contracting Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Arabian Bemco Contracting Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • PACCAR Inc.:戦略・SWOT・企業財務分析
    PACCAR Inc. - Strategy, SWOT and Corporate Finance Report Summary PACCAR Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆